Condition: Ischemic Stroke · Sponsor: General Hospital of Shenyang Military Region
The purpose of this prospective cohort study is to investigate whether antithrombotic therapy in the secondary prevention of ischemic stroke increases the risk of the emerging CMBs and whether the change is associated with an increased risk of intracranial hemorrhage, providing an imaging evidence for individualized antithrombotic therapy in such patients.
This description comes directly from the study's public registry record.
chen huisheng, doctor · 86-24-28897511 · chszh@aliyun.com
wang xinhong, doctor · 15309885658 · 450341972@qq.com
Always discuss trial participation with your own doctor first.
| General Hospital of ShenYang Military Region | Shenyang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03571763